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Abstract
Many questions remain about the significance of structural features of integrin αVβ3 for its
mechanism of activation. We have determined and re-refined, respectively, crystal structures of
the αVβ3 ectodomain linked to C-terminal coiled-coils (αVβ3-AB) or four transmembrane (TM)
residues in each subunit (αVβ3-1TM). The αV and β3 subunits with four and eight extracellular
domains, respectively, are bent at knees between the integrin headpiece and lower legs, and the
headpiece has the closed, low-affinity conformation. The structures differ in occupancy of three
metal binding sites in the βI domain. Occupancy appears related to the pH of crystallization, rather
than to physiologic regulation of ligand binding at the central, metal-ion dependent adhesion site
(MIDAS). No electron density was observed for TM residues and much of the αV linker. αVβ3-
AB and αVβ3-1TM demonstrate flexibility in the linker between their extracellular and TM
domains, rather than previously proposed rigid linkage. A previously postulated interface between
the αV and β3 subunits at their knees was also not supported, because it lacks high quality density,
required rebuilding in αVβ3-1TM, and differed markedly between αVβ3-1TM and αVβ3-AB.
Together with variation in domain-domain orientation within their bent ectodomains between
αVβ3-AB and αVβ3-1TM, the structures are compatible with the requirement of large structural
changes, such as extension at the knees and headpiece opening, in conveying activation signals
between the extracellular ligand-binding site and the cytoplasm.
Introduction
Integrins have noncovalently associated α and β subunits, each with an ectodomain (~ 1,000
residues in α and ~ 700 in β), a single transmembrane domain, and a typically short
cytoplasmic domain. Integrin ectodomains have four domains in α and eight in β, of which
one in each associate tightly to form a ligand-binding head (Fig. 1). The remaining domains
connect the heads through upper legs, knees, and lower legs, to the plasma membrane. In the
bent conformation, the knees are bent, and the headpiece (head and upper legs) folds over
the lower legs, to form a 2,000 Å2 interface (Fig. 1A). In two extended conformations, the
legs are extended at the knees, and the headpiece may either be closed, as in the bent
conformation, or open (Fig. 1B and C). Headpiece opening involves a large conformational
change at the hybrid domain interface where the βI domain is inserted, i.e. attached at both
its N- and C-termini. Headpiece opening is conveyed by α-helix connecting rod-like
movements across the βI domain to its interface with the α-subunit where the ligand is
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bound, and increases affinity for ligand many orders of magnitude (Fig. 1C). Most integrins
interact with the actin cytoskeleton, and transmit signals in both directions across the
membrane to regulate binding to extracellular ligands, and traction through the cytoskeleton
for cell migration and signaling (1).
The key question in the integrin field is how signals are transmitted from integrin
cytoplasmic and transmembrane domains to the ligand-binding site in the ectodomain to
regulate affinity for ligand. We and others have presented extensive evidence for two key
types of conformational changes: 1) integrin extension to give the extended-closed state
(Fig. 1B) and 2) integrin headpiece opening to give the extended-open state (Fig. 1C) (1).
The extended-closed conformation has low affinity for ligand, and only the extended-open
conformation has high affinity (2-9). Thus integrin activation by inside-out signals increases
the proportion of integrins with the extended-open conformation. These conclusions are
supported by a large number of electron microscopy (EM), small angle X-ray scattering
(SAXS), and crystallographic studies as well as affinity measurements on cell surfaces. The
studies include work on diverse integrins including αVβ3, αIIbβ3, α5β1, αVβ6, αLβ2, and
αXβ2 (1). To communicate allostery over unusually large distances through the flexible
lower leg of the β-subunit in the extended conformation, it has been emphasized that large
separations between the integrin transmembrane and cytoplasmic domains would be
required, and evidence for such separation has been obtained by transmembrane domain
cross-linking and fluorescence resonance energy transfer (FRET) experiments (10-12).
On the other hand, another model proposes that integrin activation requires neither extension
nor headpiece opening (13, 14). The body of evidence supporting this alternative model is
smaller, and is based on studies of integrin αVβ3 (13, 14). Crucial in the latest support for
this hypothesis was a crystal structure of integrin αVβ3 (14). Excellent density was reported
for the ectodomain, as well as the first three residues of both the αV and β3 TM residues. It
was unexpected that the αV and β3 TM residues were far from one another in the crystal
structure (25 Å), because structures for the closely related αIIb and β3 TM domains show the
same residues in close contact (15-17). Nonetheless, a model was made by bending the
ectodomain-TM linkers in both αV and β3 to bring the TM domains close, and it was
suggested that some rigidity in the linker region is essential to maintain the integrin in its
inactive conformation (14). Linker rigidity sets αVβ3 apart from integrins αIIbβ3 and αXβ2.
Ectodomain-TM domain linkers were disordered in αIIbβ3 and αXβ2 crystal structures,
suggesting flexibility (18, 19). Furthermore, disulfide cross-linking of the αIIb and β3 linkers
on intact αIIbβ3 on cell surfaces demonstrated lack of a specific interface (15).
Several other features of αVβ3 crystal structures appear unusual. The βI MIDAS locates in
between two other divalent metal-binding sites, the adjacent to MIDAS (ADMIDAS) and
synergistic metal-binding site (SyMBS). αVβ3 was found to lack metal ions at the MIDAS
and SyMBS, but to contain them when a ligand was soaked in, and metal ions were
suggested to regulate ligand binding (14, 20). In contrast, αIIbβ3 with an identical β-subunit,
binds metal ions at all three sites in absence of ligand (18, 21). αVβ3 has been reported to
have clear density at its β-knee (14), in contrast to αIIbβ3 (18). A specific, stabilizing
interface between the αV and β3 knees was reported that is unusual for containing many
hydrogen bonds between highly solvent-accessible carbonyl and carboxyl groups (14). Such
carboxyls are considered to be deprotonated at physiologic pH, and interactions between
oxygen lone pair electrons are highly unfavorable. A specificity-determining loop (SDL) in
the βI domain of the β3 subunit near the ligand-binding interface with the α-subunit was
built markedly differently in a 2004 αIIbβ3 crystal structure (4) than in the 2001 αVβ3
crystal structure (22). The conformation in αVβ3 was retained in the 2009 crystal structure
(14), perhaps implying an influence of the α-subunit on the conformation of the nearby SDL
in β3.
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To obtain an independent view of integrin αVβ3, we have determined a structure of its
ectodomain fused to coiled-coil peptides to mimic associating TM α-helices (αVβ3-AB).
Furthermore, to better address special issues raised by the αVβ3-1TM structure, we carefully
examined this structure and its underlying electron density. After doing so, we decided that
it would benefit from re-refinement. Therefore, we report here two different αVβ3 crystal
structures. Using these structures and their objective electron density, we report several
novel structural features, and come to novel conclusions on the bent-closed structure of
αVβ3 and its implications for activation.
Materials and Methods
Clasped αVβ3-AB ectodomain structure
The αV ectodomain sequence ending at M960 was fused to sequences in the order
GSGGEN, AQCEKELQALEKENAQLEWELQALEKELAQ, corresponding to a 6-residue
vector-derived sequence and the ACID-p1 sequence of peptide Velcro (23) containing a Cys
at the “d” position of the heptad repeat (24), respectively. The β3 ectodomain sequence
ending at P691 was fused to sequences in the order ESM, LENLYFQ, GGKN,
AQCKKKLQALKKKNAQLKWKLQALKKKLAQ, TG, and HHHHHH, corresponding to
a three-residue linker, a tobacco etch virus (TEV) protease site, a four-residue linker, the
BASE-p1 sequence of peptide Velcro (23) containing a Cys at the “d” position of the heptad
repeat (24), a two-residue linker, and a His6 tag, respectively (2). Protein was expressed in
CHO Lec 3.2.8.1 cells (2) and purified from culture supernatant using Ni-NTA agarose
(QIAGEN) followed by gel filtration (Superdex 200 HR) chromatography in 0.01 M Tris
HCl pH 7.5, 0.14 M NaCl (TBS), and 1 mM Ca2+, and was concentrated to about 5.5 mg/ml.
Crystals from hanging-drop vapor diffusion at room temperature were in 2 M ammonium
sulfate, 80 mM sodium cacodylate pH 5.8, 2 mM CaCl2 and 6 mM MgCl2. Coverslips with
their hanging drops were transferred to wells containing saturated ammonium sulfate for
dehydration over 16 h. Crystals were cryoprotected in 95% saturated ammonium sulfate and
5% glycerol before plunge freezing in liquid nitrogen.
Diffraction data from GM/CA-CAT beamline 23-ID of Advanced Photon Source (APS) at
Argonne National Laboratory were processed using XDS (25). The structure was solved
using molecular replacement with PHASER with both 3IJE and 4G1M αVβ3-1TM
structures (described below). The rotation function and translation function Z scores,
respectively, were 15.0 and 26.5 for the 3IJE model, and 16.2 and 38.1 for the 4G1M model.
Initial structure refinement with PHENIX (26) used rigid bodies for individual domains,
individual sites, TLS, and individual B factor refinement. Using the same parameters, we
obtained Rwork and Rfree of 27.4% and 33.7% with 3IJE and 24.4% and 31.4% with 4G1M
models, respectively. Like the better molecular replacement scores with the 4G1M model,
these refinement results showed that the 4G1M αVβ3-1TM model fit better the αVβ3-AB
dataset than the 3IJE αVβ3-1TM model. The initial αVβ3-AB model obtained using
replacement with the 4G1M αVβ3-1TM model was therefore used as the starting model for
subsequent refinement.
After several rounds of manual model rebuilding with Coot (27) and refinement with
PHENIX, simulated annealing was used in refinement instead of rigid body refinement.
Simulated-annealing composite omit maps were also calculated and used to guide manual
rebuilding to decrease model bias. During iterative rebuilding and refinement, an 8% twin
fraction was observed in the dataset with the twin law H, K, -L. After applying the twin law,
both Rwork and Rfree dropped around 1.5%. The ACID and BASE α-helical coiled-coil
(leucine zipper) peptides, but not the linkers to the C-termini of the αV- and β3-subunits,
were present in electron density and were added to the model.
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Refinement was first completed at 3.0 Å resolution. Using a recent cross-correlation method
(28), we found that useful data extended to 2.85 Å. Density improved, and refinement was
extended to this resolution.
Refinement of 3IJE
We calculated simulated-annealing (SA) composite omit maps using the αVβ3-1TM (PDB
code 3IJE) coordinates and structure factor amplitudes with both the programs CNS (29) and
PHENIX (26). Neither program's SA omit maps showed 1σ electron density for a substantial
portion of the β3 I-EGF1 domain, portions of the I-EGF2 and PSI, much of the α-subunit
linker, or the TM segments of the α- and β-subunits.
Based on these results, we started with a model lacking the PSI, I-EGF1, and I-EGF2
domains, and systematically rebuilt the αVβ3 structure in 16 iterative steps of manual
rebuilding with Coot (27), attention to outliers and clashes identified with MolProbity (30),
and TLS and maximum-likelihood refinement with REFMAC (31). PyMol scripts were used
to superimpose individual domains from high resolution αIIbβ3 structures to provide hints
for rebuilding. At each step, we computed PHENIX simulated annealing composite omit
maps (26). The PSI and most of the I-EGF1 and I-EGF2 domains appeared in the 2Fo-Fc
map during refinement and were added back. Rfree dropped from 28.5% in 3IJE to 26.9%.
Another SA omit map calculated with CNS showed most of I-EGF1.
Many further cycles of rebuilding in Coot utilized PHENIX refinement with TLS, maximum
likelihood, and simulated annealing (26). Rfree dropped to 24.2%. Subsequent refinement
cycles without simulated annealing resulted in a final Rfree of 23.4%. In the last cycle,
EGF-1 was carefully examined. Only short segments were missing in the 1 σ 2Fo-Fc map;
however, the overall quality of the map remained lower than for other domains, suggesting
flexibility. A low-resolution map computed from data between ~ 65 and 3.7 Å was used to
check this less-ordered domain. This map clearly showed the N-acetyl glucosamine residue
attached to β3 Asn-452, which was added back. The C-termini of αV and β3 were each
extended about two residues past the last residue in the 1 σ map, to the last peptide moiety in
~ 0.5 σ density, beyond which there could be no confidence in the path of the polypeptide
chain.
αVβ3 furin site mutation and function
Full-length human αV and β3 plasmids were subjected to site-directed mutagenesis and co-
transfected into HEK293T cells as previously described (2). Cell surface expression
measured with non-functional Cy3-conjugated β3 mAb AP3 and binding of Alexa-488
conjugated fibrinogen and fibronectin were determined by fluorescent flow cytometry (8).
Briefly, transfected cells were detached, re-suspended in 20 mM HEPES-buffered saline, pH
7.4 (HBS), supplemented with 5.5 mM glucose and 1% bovine serum albumin and
incubated in room temperature for 30 min with human fibrinogen or fibronectin in the
presence of either 5 mM EDTA, 5 mM Ca2+, or 1 mM Mn2+. Cells were then stained with
Cy3-conjugated AP3 on ice for 30 minutes.
Transiently transfected cells were metabolically labeled with [35S] cysteine/methionine and
subjected to immunoprecipitation as described (11). Lysates in 20 mM Tris-buffered saline,
pH 7.4 (TBS), supplemented with 1 mM Ca2+, 1% Triton X-100, 0.1% Nonidet P-40 and
1:100 v/v protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) were
immunoprecipitated with 1 μg of αVβ3 mAb LM609 (EMD Millipore Corporation,
Billerica, MA) and protein G-Sepharose at 4 °C for 1 h.
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Previously described αVβ3-ΔTM (22) and αVβ3-1TM proteins (14) were each expressed in
insect cells, differ in length from one another only by four TM residues in each subunit, and
crystallize with 10 to 12% PEG as precipitant in nearly identical lattices. The spacegroup is
P3221, and the unit cell dimensions are a = b = 130.0 Å (αVβ3-ΔTM) or 130.26 Å
(αVβ3-1TM) and c = 307.3 Å (αVβ3-ΔTM ) or 305.98 Å (αVβ3-1TM). Such small
differences in lattice dimensions are typical for different crystals of the same protein.
To obtain an independent view of αVβ3 structure, we expressed in mammalian CHO-Lec
cells the complete αVβ3 ectodomain, connected through 6-residue (αV) and 14-residue (β3)
linkers to the ACID and BASE leucine zipper Velcro peptides (2, 23) (αVβ3-AB). Crystals
formed with a different class of precipitant, 2 M ammonium sulfate. The spacegroup was
still P3221, and the a and b dimensions of 128.46 Å were similar to those of 130.26 Å for
αVβ3-1TM; however, at 352.49 Å the c dimension was markedly larger than 305.98 Å for
the previous crystals (Table 1). The structure includes the ACID-BASE leucine zipper;
however, it has little if any effect on αVβ3 because the long linkers between the αV and β3
subunits and the ACID and BASE peptides are disordered. The 2.85 Å αVβ3-AB structure
(Fig. 2A) is well refined, with Rfree of 26.2%, excellent Ramachandran and geometry
statistics, and high MolProbity (30) percentiles (Table 1).
αVβ3-1TM ectodomain structure
The 2.9 Å αVβ3-1TM structure was solved by molecular replacement (14) and is therefore
subject to model bias. The standard method for obtaining a less model-biased map is to
compute a simulated-annealing (SA) composite omit map (32). Independent SA composite
omit maps were calculated with CNS and PHENIX using the deposited αVβ3-1TM (PDB
code 3IJE) data. The maps showed absent or poor electron density for much of the PSI, I-
EGF1, and I-EGF2 domains, the linker between the ectodomain and TM domains, and TM
domain residues. Furthermore, difference map peaks showed a substantial number of places
where the 3IJE model and the electron density did not correlate (Fig. 3A, red and green
mesh).
Therefore, we rebuilt the αVβ3-1TM molecular model using many iterative steps of
rebuilding with Coot and refinement that included use of REFMAC, PHENIX, and
simulated annealing. We initially omitted regions with poor density. As other domains
improved, 1σ density for PSI, I-EGF1, and I-EGF2 reappeared, and these domains were
added back. We re-calculated SA composite omit maps after each refinement step, and used
MolProbity to find clashes, bad rotamers, and Ramachandran outliers after each refinement.
Density for C-terminal portions of αV and β3 did not reappear and they are thus absent in
the final model.
The new and previous αVβ3-1TM molecular models are referred to here by their PDB
accession codes, 4G1M and 3IJE, respectively. If the PDB code is not specified, αVβ3-1TM
refers to the 4G1M structure. The 4G1M structure has many fewer regions of disagreement
with electron density (Fig. 3B) than 3IJE (Fig. 3A). Furthermore, 4G1M is refined against
data from 2.9 - 65 Å, as opposed to 2.9 - 20 Å for 3IJE (Table 1). The greater amount of
low-resolution data used in 4G1M allows better definition of less ordered regions, i.e. the
PSI, I-EGF1 and I-EGF2 domains (Fig. 2B). Differences in the β3 PSI, I-EGF1, and I-EGF2
domains (Cα RMSD of 1.2 - 1.4 Å, Table 2) occur throughout their length, whereas
differences in the larger integrin domains result primarily from rebuilding of loops. The
rebuilding process resulted in a drop of Rfree from 28.5 to 23.4%, a decrease in
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Ramachandran outliers from 3.1% to 0.1%, and a decrease in poor rotamers from 7.9% to
0.6%, as reported by MolProbity (30) (Table 1).
Overall structures
Both αVβ3 structures reveal an overall bent conformation (Fig. 2A and B). The αV β-
propeller and β3 βI domains interact over a large interface to form the integrin head and its
ligand binding site. Acute bends define the knees, at the junction between the upper and
lower legs. The αV leg is bent between the thigh and calf-1 domains, at the disulfide-
bonded, Ca2+ binding genu loop, or α-knee. The bend in β occurs at the β-genu between I-
EGF domains 1 and 2. Thus the thigh domain in αV and the PSI, hybrid, and I-EGF1
domains in β3 form the upper legs. The calf-1 and calf-2 domains in αV and the I-EGF2, I-
EGF3, I-EGF4 domains, β-ankle loop, and β-tail domains in β3 form the lower legs (Fig. 1).
Large interfaces are buried between the head and the lower legs, and between the αV and β3
legs, that stabilize the bent conformation (2). Since structures of αVβ3 (14, 20, 22, 33) and
αIIbβ3 (4, 18, 21, 34, 35) have previously been described, we focus our attention on the most
notable differences and the structural features that are relevant for models of integrin ligand-
binding and activation.
Lack of difference between the SDL of αVβ3 and αIIbβ3
The specificity-determining loop (SDL) extends from the βI domain at its interface with the
β-propeller domain. It locates just outside the binding footprint for small peptide ligands,
and based on exchange between different integrin β-subunits, contributes to binding of
macromolecular ligands (36). All previous αVβ3 structures (Fig. 4A) differ from all αIIbβ3
structures (Fig. 4D) over β3 SDL residues 168-176 in structure to sequence register, and by
the absence and presence, respectively, of two cis-peptides in the SDL at Ser-162/Pro-163
and Ser-168/Pro-169 (Fig. 4A and D). We wondered if these differences were induced by
differences between the αIIb and αV β-propeller domains with which the SDL associates.
However, inspection of the electron density for the previous αVβ3-1TM structure (14)
reveals clear signatures for both cis-Pro, and a sequence-to-structure shift (Fig. 4E). For
example, negative density on the carbonyl group of Pro-169 when it is trans (Fig. 4E), is
eliminated when it is cis (Fig. 4F), and positive density between the sidechains of Pro-169
and Pro-170 (Fig 4E) is satisfied by the sidechain of Pro-169 when it is cis (Fig. 4F).
Furthermore, positive densities near Glu-174, Asn-175, and Pro-176, and negative density at
Leu-173 (Fig. 4E) are corrected when the sequence-to-structure register is shifted and the
backbone is flipped at Pro-176/Cys-177 (Fig. 4F). Rebuilding to follow the electron density
resulted in SDL backbones in αVβ3-1TM (Fig. 4B) and αVβ3-AB (Fig. 4C) similar to that in
αIIbβ3 (Fig. 4D).
A metal ion at the SyMBS or MIDAS in unliganded αVβ3
The αVβ3-AB structure has no metal at the MIDAS or ADMIDAS, but has density for Ca2+
at the SyMBS (Fig. 5A and D). The αVβ3-1TM structure has only weak density at the
SyMBS, modeled as a water in 4G1M (Fig. 5B). Positive density at the MIDAS in the 3IJE
dataset (Fig. 5E) has been satisfied by placing a Ca2+ ion at the MIDAS in 4G1M (Fig. 5F).
Thus αVβ3-1TM has metal ions at both the MIDAS and ADMIDAS (Fig. 5B). The Ca2+ at
the MIDAS has higher B factors than the surrounding coordinating residues, and therefore
may have partial occupancy; furthermore, a water or Mg2+ ion (which is lacking in buffers
but could have been bound to αVβ3) could also be built at the MIDAS. The most reasonable
interpretation is Ca2+ or Mg2+, both because a metal ion is normally bound here, and
because of the close proximity of three negatively charged residues. The position of the
metal ion differs from that in αIIbβ3, which appears related to the lack of metal ion binding
to SyMBS in αVβ3-1TM and the consequent shift in position of the dual SyMBS and
MIDAS-coordinating residue Glu-220 (Fig. 5B and C). Remarkably, the occupancy of the
Dong et al. Page 6










three βI metal ion binding sites is completely reversed between αVβ3-AB and αVβ3-1TM
(Fig. 5A and B).
Overall flexibility in the ectodomain
Crystallographic B-factors reflect atomic displacements in the crystal lattice and are hence
related to protein flexibility. In the αVβ3-1TM backbone, B-factors are much higher than the
overall average in I-EGF1 and in the N-terminal portion of I-EGF2, which connects to I-
EGF1 and is near to the thigh domain (Fig. 6A). In the αVβ3-AB backbone, B-factors in the
β3 subunit are high in a long PSI domain loop, in the last disulfide-bonded loop of I-EGF1,
and in the first loop of I-EGF2, which has a gap in continuous density (Fig. 6C). In αIIbβ3,
the first loop in I-EGF2 also has high B factors, and is partially missing in density (Fig. 6E).
The highest B-factors in αIIbβ3 occur in the β-tail domain, which is poorly ordered (Fig.
6F).
The overall position of the genu moves markedly between the two αVβ3 structures (Fig. 2A
and B), and the α-genu in αVβ3-AB also has high B-factors (Fig. 6C). Genu movement is
tied to changes in position of both the thigh and calf-1 domains between the two structures.
The genu-proximal end of the calf-1 domain is 3.5 Å closer to I-EGF2 in αVβ3-AB than in
αVβ3-1TM. Furthermore, the thigh domain rotates along its long axis. Rotation is not about
the center of the domain, but is centered on β-strand-F, which faces inward toward the lower
α- and β-legs. Far from the center of rotation, the long C-D loop in thigh moves 6 Å closer
to I-EGF2 in αVβ3-1TM than in αVβ3-AB.
The other large movement between αVβ3-1TM and αVβ3-AB occurs in the PSI and I-EGF1
domains and in the PSI- and I-EGF1-proximal end of the hybrid domain. While there is little
change in position of the βI-proximal end of the hybrid domain, the PSI-proximal end of the
hybrid domain moves 2 to 2.5 Å. This libration of the hybrid domain is coupled to
displacement of 2 to 3 Å of the PSI and I-EGF1 domains, in a direction that places PSI and
I-EGF1 further away from αV in αVβ3-1TM than in αVβ3-AB.
Flexibility in I-EGF1 and I-EGF2
Flexibility occurs within I-EGF1 and I-EGF2, as well as at their junctions with other
domains. Cα-traces colored in rainbow by B factor show marked flexibility within the loops
at the C-terminal end of I-EGF1 and at the N-terminal end of I-EGF2, near the junctions
between these domains (Fig. 7). Just before the final Cys-521 of I-EGF2 (C8, Fig. 7E-G),
Tyr-520 (Y in Fig. 7E-G) participates in hydrophobic interactions with core elements of the
domain, and is shielded on one side by Lys-519 (K in Fig. 7E-G). Tyr-520 is highly
conserved as an aromatic or hydrophobic residue in I-EGF2 of other integrin β-subunits. In
contrast, I-EGF1 lacks elements that stabilize the conformation of its C7-C8 loop, and has
Ser-469 and Gln-470 (S and Q in Fig. 7A-D, respectively) at the sequence positions
equivalent to Lys-519 and Tyr-520 (Fig. 7E-G).
The flexibility of the C7-C8 loop in I-EGF1 is emphasized in αIIbβ3 headpiece structures in
which the β3 subunit terminates in I-EGF1. This loop is disordered in most such structures
(4, 34). However, in recent closed headpiece structures with two headpieces per asymmetric
unit (21, 35), the electron density is good enough to build most of the C7-C8 loop in one
molecule and all of the C7-C8 loop in the other molecule (Fig. 7D). Remarkably, this loop
adopts a markedly different orientation. Although there is room in the crystal lattice for the
C7-C8 loop to adopt the same conformation as seen in the complete ectodomain, as shown
by superposition (Fig. 7H), the C7-C8 loop instead moves to another position in the lattice,
where the backbones of Pro-464 and Gly-465 participate in a network of water-mediated
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hydrogen bonds to the β-propeller domain of a neighboring molecule in the crystal lattice of
the 2.2 Å structure.
Lack of a stable interface between the I-EGF2 and thigh domains
Substantial negative and positive Fo-Fc difference density is present in the interface between
the β3 I-EGF2 and αV thigh domains in the original αVβ3-1TM model (Fig. 3A) but not in
the map calculated using improved coordinates (Fig. 3B). This is a region of high B-factors,
particularly in I-EGF2, but also in the extended CD loop of the αV thigh (Fig. 6A and C).
Near this interface in the I-EGF1 domain, between the two αVβ3-1TM models the Cα atom
positions shift 2.3 Å for Leu-467 and 1.2 to 1.5 Å for Gly-463, Pro-464, and Gly-465. In the
C1-C2 loop of the I-EGF2 domain, at the interface with the thigh domain, the Cα atoms of
Glu-475, Glu-476, Asp-477 (Fig. 8A and B), Tyr-478, and Arg-479 shift 1.8, 1.8, 1.5, 1.6,
and 3.5 Å, respectively, between the two models. Although these residues are more
accurately located in our model, as shown by presence of backbone density in simulated
annealing composite omit maps calculated with 4G1M but not 3IJE structures (Methods),
the differences in position emphasize that these are among the regions with the poorest
electron density, and the most difficult to build.
The C1-C2 loop is markedly longer in I-EGF2 than in other integrin I-EGF domains (18).
Several residues in this loop were too disordered to build in αVβ3-AB or αIIbβ3 (Fig. 7E and
G). Missing density here and elsewhere in the molecular model is clearly not due to
proteolytic cleavage, as demonstrated by migration of the αV and β3 subunits at the
expected molecular weight in SDS-PAGE (Supp. Fig. S1).
Across from I-EGF2, the electron density on the thigh side of the interface is better;
nonetheless, substantial rebuilding was required to fit the density. Thus, in the interface the
Cα atoms of thigh residues Gln-504, Lys-505, Gly-506, and Glu-547 shift 1.4, 2.1, 1.4, and
3.1 Å, respectively, between the two models (see E547 in Fig. 8A and B). There are no
hydrogen bonds or significant hydrophobic interactions between I-EGF2 and thigh in our
model of αVβ3-1TM (Fig. 8B), consistent with the substantial shift in orientation at the I-
EGF2/thigh interface between αVβ3-1TM and αVβ3-AB (Fig. 8B and C).
Lack of a stable interface between the β-tail and βI domains
The interface between the β-tail CD (deadbolt) loop and the βI domain is extremely small in
both the 4G1M αVβ3-1TM and αVβ3-AB structures, at 40 Å2 and 50 Å2, respectively.
Furthermore, there are no significant van der Waals interactions or hydrogen bonds between
these domains. Moreover, the β-tail CD loop has high B-factors, particularly in αVβ3-1TM
(Fig. 6B).
Interaction of an αV glycopeptide moiety with β3
Near the furin cleavage site in the calf-2 domain of αVβ3-AB, we found a polypeptide-like
electron density protruding from calf-2 toward β3, into a cavity between the I-EGF4 and β-
tail domains. A second large, branched density corresponding to an N-linked carbohydrate
extends from the first density. This enabled us to identify the polypeptide density as αV
residues 841-848, and to build two N-acetylglucosamine and three mannose residues N-
linked to Asn-844 of the consensus N-glycosylation sequence (Fig. 9A). Around the furin
cleavage site at R860, residues 839-840 and 849-866 are disordered.
The αV 841-848 glycopeptide moiety inserts in a cavity between the β3 headpiece and lower
leg, and forms contacts with the βI, hybrid, I-EGF4, β-ankle, and β-tail domains (Fig. 9A).
It is unlikely to be able to occupy the same position prior to furin cleavage. Therefore, we
tested the effect on αVβ3 function of an αV-R860A mutation. This mutation eliminated the
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cleavage by furin of the αV-subunit (Fig. 9B). However, it had little effect on binding of
fibrinogen or fibronectin to αVβ3 transfectants measured by fluorescent flow cytometry
(Fig. 9C and D). In contrast, introduction of an N-linked glycan wedge into the βI/hybrid
domain interface to favor the open headpiece conformation markedly increased binding in
both Ca2+ and Mn2+ (Fig. 9C and D).
Linkage between the extracellular and transmembrane portions of αVβ3
Improvement of the molecular model of αVβ3-1TM included rebuilding of the C-terminal
portion of the calf-2 domain. The backbones of L755 and G954 were rotated, and the
backbone of W953 was flipped (Fig. 10A and B). These changes allowed these residues to
fit better into density and enabled the strong hydrogen bond between the backbones of αV
L755 and G954 to fit into continuous 1 σ 2Fo-Fc electron density (Fig. 10B). We traced
generously, i.e. using 0.5 σ 2Fo-Fc electron density, the linkers between the ectodomain and
the membrane, which have high B factors (Fig. 6B). Our αVβ3-1TM model thus extends to
the A958-P959 peptide bond in αV and the P691-D692 peptide bond in β3 (Fig. 10B). We
were unable to discern any trace of the αV and β3 polypeptide chains beyond these
positions. Thus, we were unable to build residues αV M960-I967 or β3 I693-V695 that were
included in the 3IJE model (Fig. 10A). In αVβ3-AB, we were able to build up to αV residue
P959 and β3 residue P691 (Fig. 10C).
The difficulty of tracing the αVβ3-1TM αV linker is emphasized by the markedly different
position of the A958 sidechain in the two models (Fig. 10A and B). Lack of experimental
support for the C-terminal portion of αV in the 3IJE model is further shown by negative 3 σ
Fo-Fc difference electron density on the backbone of αV residues P957, P959, M960, P961,
V962, P963, W965, and V966, as well as on the sidechain of W965 (Fig. 10A). Scattered 1
σ 2Fo-Fc electron density in this region of the 3IJE backbone (Fig. 10A) did not appear in
electron density calculated using the 4G1M model (Fig. 10B), suggesting that this density
was due to model bias. Absence of αV residues 960-967 in our model eliminated negative
Fo-Fc difference electron density, and positive electron density did not appear along the
omitted backbone (Fig. 10B).
We were also unable to build β3 TM residues I693-V695 (Fig. 10B). Continuous negative 3
σ Fo-Fc electron density is present along the backbone of β3 residues 691-695 in the 3IJE
dataset (Fig. 10A), providing evidence against the path built for these residues. In this region
of the electron density map for the 4G1M αVβ3-1TM model, no negative or positive
difference electron density appears (Fig. 10B).
Discussion
Differences among crystal structures
Two crystal structures of αVβ3 have revealed unanticipated features in this well-studied
integrin. The SDL is functionally important for binding macromolecular ligands (36).
Although previous structures suggested major conformational differences between this β3
loop in αVβ3 and αIIbβ3, new αVβ3 structures reported here reveal no significant
differences. The SDL loop in β3 is thus little influenced by the associating α-subunit.
Three metal binding-sites are present at the ligand binding site of the integrin βI domain.
Density appropriate for a metal ion is present at the MIDAS in αVβ3-1TM, when phases are
calculated using 3IJE or 4G1M coordinates. This contrasts with the previous assertion that
no metal was present at this site in αVβ3-1TM (14); however, our interpretation of a metal
ion at the MIDAS is consistent with report of a density feature at this site in the αVβ3-ΔTM
structure (22). In αVβ3-AB only the SyMBS site is occupied, whereas in αVβ3-1TM only
the MIDAS and ADMIDAS are occupied (Fig. 5). In contrast, all three metal ion binding
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sites are occupied in unliganded αIIbβ3 crystal structures (18, 21). The SyMBS had
previously been designated LIMBS, for ligand-induced or –associated metal binding site
(20). However, our αVβ3-AB structure clearly demonstrates that ligand binding is not
required for occupancy of this site, supporting earlier observations with αIIbβ3 and the
SyMBS designation (18, 21). Previous studies have shown that binding of Ca2+ to the
SyMBS and Mg2+ to the MIDAS is synergistic (37); this synergism is explicable both by the
close proximity of these two metal ion-binding sites, and bidentate coordination of the
Glu-220 sidechain to both the SyMBS and ADMIDAS metal ions (Fig. 5C).
The striking differences between metal ion binding to identical β3 subunits in αVβ3 and
αIIbβ3 may be due to crystallization conditions. The use of both Mg2+ and Ca2+ in αIIbβ3
(18, 21) and αVβ3-AB crystals, and only Ca2+ or only Mn2+ in αVβ3-ΔTM and αVβ3-1TM
crystals (14, 20, 22, 33) may be one factor. The use of PEG and ammonium sulfate as
precipitants in crystallization of αVβ3-1TM and αVβ3-AB, respectively, may also contribute
to differences. The different pH ranges at which αVβ3 and αIIbβ3 crystallize may be the
major factor. αVβ3-ΔTM crystallized at pH 6.0 (22); αVβ3-1TM was variously reported to
crystallize at pH 5.5 in the publication or pH 4.8 in the deposited coordinates (14); and
αVβ3-AB crystallized at pH 5.8. Among αIIbβ3 structures in absence of ligand, the complete
ectodomain crystallized at pH 7.0 (18) and the headpiece at pH 8.9 (21). Asp and Glu have
pK values of 3.9 and 4.3, respectively. When these residues are close to other negatively
charged residues, as they are at the SyMBS, MIDAS, and ADMIDAS, Coulomb's law
dictates an increase in pK (38). This effect could easily result in substantial protonation of
metal-coordinating residues in the pH range 4.8 to 6.0 used in crystallization of αVβ3, and
hinder occupation of metal-binding sites. In contrast, the same residues would be more
ionized at the physiologic pH of 7.4, and at pH 7.0 and 8.9 as used in αIIbβ3 crystallization.
In contrast to the βI domain sites, the β-propeller β-hairpin Ca2+-binding sites and genu are
well occupied in αVβ3 crystals. This difference is easily explicable by the close spatial
relationship of the SyMBS, MIDAS, and ADMIDAS to one another (38). Furthermore, the
MIDAS and ADMIDAS have more water coordinations than any of the other integrin metal
ions.
These observations suggest that the lack of simultaneous metal ion-binding to all three βI
domain sites in αVβ3 is most simply explained as an artifact of crystallization conditions.
An alternate explanation, that the sidechain of SyMBS residue Asp-217 orients differently in
αVβ3 than in αIIbβ3 (14) encounters the issues that 1) either orientation fits the electron
density at 2.9 Å and we have built the same orientation in αVβ3-1TM and αVβ3-AB as in
αIIbβ3; 2) the orientation we have built is required to coordinate the SyMBS metal ion and
satisfy all six octahedral coordination positions; 3) Fig. 2B of (20) shows Asp-217 of αVβ3-
ΔTM in the same orientation as we have built in αVβ3-1TM; and 4) the Asp-217 orientation
built in the 3IJE model is disfavored by overlap of the electron orbitals of Oδ1 of β3
Asp-217 and Oδ1 of αV of Asp-219, which are only 2.8 Å apart.
The concept that Ca2+ and Mg2+ bind synergistically at the SyMBS and MIDAS (18), and
that at low pH conditions with αVβ3, metal binding and ligand binding are also synergistic,
is more plausible than the concept that ligand binding is regulated by or induces metal ion
binding (39). It would be difficult for the Asp of RGD to bind to the MIDAS in the absence
of a metal ion and in the face of strong repulsion from negatively charged MIDAS residues.
Furthermore, the SyMBS site is buried, and metal ion access to this site would be further
limited after ligand binding.
The remarkable contact of a furin cleavage site-proximal αV glycopeptide moiety with the
β3 subunit seen here might also be dependent on crystallization conditions. (NH4)2SO4 was
the αVβ3-AB precipitant, whereas in the αVβ3-1TM crystal structure with PEG precipitant,
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no density for a similar glycopeptide moiety is discernable. These differences are in
agreement with the highly polar interactions of the αV glycopeptide moiety with β3, which
are expected to be easily replaceable with water or PEG. We found no effect of furin
cleavage on basal or Mn2+-stimulated αVβ3 ligand binding, although effects might emerge
in other assays. Mutational elimination of furin cleavage sites has little effect on ligand
binding in αIIbβ3 and α4β1 (40, 41) but is required for inside-out stimulation of adhesion by
α6β1 (42).
Implications for integrin activation
A deadbolt model proposed that removing β-tail domain constraints on the βI domain could
induce integrin activation without extension (43). In the original proposal of this hypothesis,
it was acknowledged that the β-tail domain CD or “deadbolt” loop had high temperature
factors, buried a very small surface area on the βI domain, and was unlikely to contribute
stabilizing energy in the conformation seen in the αVβ3-ΔTM structure; therefore, it was
suggested that minor rearrangements might result in a larger interface in intact αVβ3 on the
cell surface (43). However, deletion of the β-tail domain CD loop has no activating effect
whatsoever on αVβ3 and αIIbβ3 on cell surfaces (44). Moreover, despite the negligible
contact between the β-tail CD loop and the βI domain in αVβ3-ΔTM, there is even less in
αVβ3-1TM, none in αVβ3-AB where the CD loop is disordered, and none in αIIbβ3 (18).
Another interface, between the αV thigh domain and β3 I-EGF2 domains, was recently
proposed to be an energetic barrier, that when overcome, could enable αVβ3 activation in
the absence of extension (14). However, electron density is poor at this interface. We found
it necessary to substantially rebuild PSI, I-EGF1, I-EGF2, and loops in thigh adjacent to I-
EGF2 in our αVβ3-1TM model. Cα atom positions in loops relevant to a proposed interface
are shifted substantially between the 3IJE and 4G1M αVβ3-1TM models. Furthermore, the
sidechain orientations shown in Fig. 4D in (14) are inconsistent with the associated 3IJE
coordinate file, and suggest that different coordinate files were used for figure preparation
and coordinate deposition. Thus, Fig. 4D in (14), but not the 3IJE coordinates (Fig. 8A)
show hydrogen bonds between the αV Glu-547 sidechain and β3 Asp-477 backbone, and
between the αV Phe-548 backbone and β3 Glu-476 sidechain. However, questionable
hydrogen bonds between the sidechains of αV Asp-550 and β3 Glu-500, and between the
backbone carbonyl of αV Glu-547 and sidechain of β3 Glu-476, remain in the 3IJE
coordinate file (Fig. 8A). The 4G1M αVβ3-1TM coordinate file lacks favorable, as well as
unfavorable polar interactions in the same region (Fig. 8B). The lack of a stable interface
here, and its irrelevance for regulation of integrin affinity state, is further supported by its
marked reorientation in αVβ3-AB (Fig. 8C), with no attendant reshaping of the βI domain
ligand binding site. These results are consistent with extensive mutagenesis evidence that the
loop between cysteines 1 and 2 of I-EGF2 acts as an entropic spring, and that its length, but
not its sequence, is important in regulating the equilibrium between bent and extended
integrin conformations (45).
In αVβ3-1TM, we were unable to trace αV linker residues Met-960 to Pro-963, αV TM
residues Val-964 to Ile-967, or β3 TM residues Ile-693 to Val-695. Strong evidence against
the placement of αV residues 960-967 and β3 residues 693-695 is shown by the presence of
3 σ negative difference electron density along this backbone and on the sidechain of αV
Trp-965 in 3IJE (Fig. 10A), and the lack of appearance of positive difference electron
density in the corresponding regions of the 4G1M αVβ3-1TM model (Fig. 10B). Flexibility
in the αV and β3 linkers is further evidenced by differences in orientation between
αVβ3-1TM and αVβ3-AB beginning with αV residue Gln-956 and β3 residue Lys-689 (Fig.
10B and C).
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Flexibility of ectodomain linker residues αV 956-963 and β3 689-692 is to be expected from
the lack of stabilizing interactions in the linker structures (Fig. 10B and C). The last residue
well supported by structural interactions in αV is G954, which has a backbone hydrogen
bond to L755 (Fig. 10B and C). Similarly, the last such residue in β3 is C687, which is
disulfide-bonded to C663 (Fig. 10B and C).
Our conclusion that the αV and β3 linkers are flexible is in excellent agreement with a
similar lack of density for the corresponding regions in αIIbβ3 and αXβ2 crystal structures
(18, 19). Furthermore, the use of disulfide cross-linking restraints in the linker regions of
intact αIIbβ3 on cell surfaces showed that the αIIb and β3 linkers are flexible, and even
without any motions internal to the bent conformation of αIIbβ3, enable marked change in
orientation of the ectodomain with respect to the membrane (15). However, there are limits
to linker flexibility; coupling of conformational change between extracellular and TM
domains is disrupted by insertions of 10 to 11 extra residues (15, 46). The finding that
signals can be transmitted across membranes despite flexibility of extracellular linkers has
also emerged in the epidermal growth factor receptor field, where spatial proximity between
two monomers, rather than precise orientation, is important in transmembrane signaling by
dimers (47).
We also reveal differences in positions of the structured domains in the two snapshots of the
ectodomain in αVβ3-1TM and αVβ3-AB. A large number of leg domains, three in α and six
in β, intervene between integrin ligand-binding domains and the ectodomain-TM domain
linkers. As demonstrated in variation in orientation between these leg domains in
αVβ3-1TM and αVβ3-AB (Table 2), changes in TM domain orientation could be dissipated
by change in leg domain orientation. Any alternative theory of integrin activation within the
bent conformation should propose a specific interdomain pathway for signal transmission,
and a change in orientation between the α and β subunit TM domains sufficiently large in
magnitude to prevent damping of transmission by ectodomain flexibility. The only specific
pathway in the ectodomain described to date for transmitting conformational change to the
ligand-binding site is through hybrid domain swing-out (4). Such a large conformational
change, including a 70 Å increase in separation at the knees, is incompatible with
maintenance of a compact, bent conformation.
Many mutational studies on αV and β3 support the importance of integrin extension, lower
leg separation, and headpiece opening in integrin activation. Interfaces between the αV and
αIIb calf-2 domain and β3 I-EGF4, β-ankle, and β-tail domains are required for maintaining
the low-affinity state; these interfaces prevent lower leg separation (48, 49). Interfaces
between hybrid domain and β-tail domain (50), and between the αV β-propeller domain and
the upper β-leg (51) stabilize the low-affinity state by preventing integrin extension.
Mutations that open up disulfide bonded loops in the I-EGF domains (52, 53) or introduce
bulky residues (54) or N-glycosylation sites (55) into portions of the β-leg that are buried in
the bent conformation activate αVβ3 and αIIbβ3; these mutations destabilize the bent
conformation. Mutational introduction of disulfides to prevent integrin extension (2, 56),
headpiece opening (2, 56), or lower leg separation (56) abolish activation of αVβ3.
Stabilizing the open headpiece relative to the closed headpiece with glycan wedges or
computationally predicted mutations stimulated αVβ3 and αIIbβ3 integrin activation and
LIBS epitope exposure (8, 57). Conversely, stabilizing the closed headpiece with a disulfide
bond in the βI domain or computationally predicted mutations inhibited activation (57, 58).
In summary, extensive mutagenesis and structural studies of αVβ3 and αIIbβ3 have
demonstrated the importance of multiple interfaces between the integrin headpiece and
lower legs, and between the integrin α- and β-legs, that are present in the bent conformation
and restrain integrin activation. These interfaces involve large buried surface areas and well-
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ordered sidechains, and thus contrast with the interfaces discussed above between the β-tail
and βI domains and between the α- and β-knees. Integrin extension, lower leg separation,
and headpiece opening have each been shown to be required for integrin activation. The
structures described here provide a sound foundation for better understanding of the
complex molecular mechanisms that regulate integrin activation.
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Abbreviations
MIDAS Metal ion-dependent adhesion site
ADMIDAS adjacent to MIDAS
SyMBS synergistic metal binding site
TM transmembrane
LIBS ligand-induced binding site
EM electron microscopy
FRET fluorescence resonance energy transfer
SAXS small angle X-ray scattering
PDB Protein Data Bank
TEV tobacco etch virus
APS Advanced Photon Source
MR molecular replacement
ML maximum likelihood
NMR nuclear magnetic resonance
SDL specificity-determining loop
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The three major integrin conformational states. A. Bent (with closed headpiece). B.
Extended with closed headpiece. C. Extended with open headpiece. The dashed lower β-legs
show that because of β-leg flexibility in the extended conformation, the closed and open
headpieces are each compatible with TM domain close association and separation. However,
a lateral force exerted by the cytoskeleton on the β-subunit can enforce TM domain
separation and the open headpiece conformation (1).
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Overall structures of two αVβ3 crystal forms and comparison to αIIbβ3. A-C. Cartoons of
αVβ3-AB (A), αVβ3-1TM (4G1M structure, B), and αIIbβ3 (C). Ca2+ and Mg2+ ions are
shown as silver spheres. Disulfides are shown as gold sticks, and glycans are displayed with
gray carbons.
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Difference maps. Difference maps of 3IJE (A) and 4G1M (B) αVβ3-1TM structures. Fo-Fc
difference density is shown in green (+3 σ) and red (-3 σ). The head and upper legs of αV
and β3 are shown in light blue and wheat, respectively, and the lower αV and β3 legs are
shown in yellow and black, respectively. C-termini are labeled for αV and β3.
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The conformation of the specificity-determining loop in the βI domain. The SDL and
surrounding area (A-D) or a portion of the SDL loop (E-G) are shown for the 3IJE (A and E)
or 4G1M (B and F) αVβ3-1TM structures, αVβ3-AB (C and G), and αIIbβ3 (D). β- and α-
subunits are wheat and light blue, respectively. Mesh in E-G shows 2 Fo-Fc density at 1 σ
(grey) or Fo-Fc difference density at 3 σ (green) and -3 σ (red).
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The metal ion binding sites in the βI domain. A-C. Differences in metal binding to the βI
domain among αVβ3-AB (A), αVβ3-1TM (B), and αIIbβ3 (C). D-F. Density at the metal-
binding sites. D. The SyMBS in αVβ3-AB. E and F. The MIDAS in 3IJE (E) and 4G1M (F)
αVβ3-1TM structures. Black mesh shows 2Fo-Fc density at 1 σ, and green and red mesh
show Fo-Fc difference density at 3 σ and -3 σ, respectively. Ca2+ and Mg2+ ions are shown
as gold and silver spheres, respectively. Oxygens are red and waters are small red spheres.
Dashed lines in A-C show metal coordination.
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Flexibility among αVβ3 crystal forms and αIIbβ3 assessed by B factor distributions. The
orientations are similar to those in Fig. 2A-C, except in the lower panels the integrins are
rotated about the axis vertical in the page. Integrins were superimposed as in Fig. 2, and
separated horizontally on the page. Cα-traces show B factors in rainbow, set using the
lowest and highest Cα B factors in each integrin as the blue and red ends of the rainbow,
respectively. The B factors shown include contributions from TLS. The genu Ca2+ ions are
shown as spheres and also colored by B factor. Disulfide bonds are silver. The names of the
αV, αIIb, and β3 subunits are shown next to their C-termini.
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The I-EGF domains at the β3-knee. A-G. I-EGF1 and I-EGF2 domains from structures
determined here, the αIIbβ3 ectodomain (18), or the closed αIIbβ3 headpiece (PDB ID 3T3P)
(35) were superimposed, and are shown in identical orientations aligned vertically and
horizontally on the page. Cα ribbons are rainbow colored from lowest (blue) to highest (red)
Cα B-factor in each domain. Disulfide bonds are color-coded and cysteines numbered
according to the same scheme as shown in panel I. Selected sidechains (S469 and Q470 in I-
EGF1 and the equivalent K519 and Y520 in I-EGF2) are shown. The C-terminus of I-EGF1
is indicated by showing the Cα-C bond of C8 in silver. H. The markedly different
orientation of the I-EGF1 domain C7-C8 loop in a closed headpiece crystal structure (blue)
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is shown by superimposing the I-EGF1 domain of αVβ3-AB (red). Surrounding molecules
in the closed headpiece crystal lattice are shown in different colors. I. Sequence alignment of
the β3-integrin I-EGF domains.
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Lack of stable interfaces between I-EGF2 and thigh domains. Interfaces are shown in
identical orientations after superposition of the ectodomains using the super command of
PyMol. Thigh (green) and I-EGF2 (yellow) are shown with red oxygen and blue nitrogen
atoms. All inter-subunit hydrogen bonds found as polar contacts by PyMol are shown with
dashed lines. Only 2 of the 11 hydrogen bonds shown in Fig. 4D of Xiong et al. (14) appear
in (A), either because highly solvated carboxyl-carboxyl and carboxyl-carbonyl interactions
are considered repulsive at neutral pH or the distances are too far; the orientations shown in
Fig. 4D of reference (14) differ markedly from the deposited 3IJE coordinates. All sidechain
or backbone atoms shown in Fig. 4D of reference (14) are shown in stick.
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Interaction of an αV glycopeptide moiety near the furin cleavage site with β3. A. Interaction
of the glycopeptide with the β-subunit. The glycan N-linked to αV-Asn-844 of the calf-2
domain (orange) inserts into the pocket formed by I-EGF4 domain (light blue), β-ankle
(pink), β-tail domain (green), hybrid domain (yellow) and βI domain (red). Carbohydrate
residues are displayed with gray carbons. αV residues 838, 841, 848, and 867 are marked,
which are adjacent to positions missing in density. B. Verification of furin cleavage site
mutation by immunoprecipitation of [35S]-labeled αVβ3 followed by reducing SDS 7.5%
PAGE and fluorography. C and D. Ligand binding to cells with wild-type or mutant αVβ3
measured by fluorescent flow cytometry. Binding of fluorescently labeled fibrinogen or
fibronectin to transfectants was tested in 5 mM EDTA, 5 mM Ca2+, or 1 mM Mn2+. The
wedge mutant (8) was used as positive control. Results are expressed as mean fluorescent
intensity of Alexa-488 conjugated ligand as a percentage of mean fluorescent intensity of
Cy3-conjugated AP3 antibody to β3.
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The structure of the linkers between the αVβ3 ecto and transmembrane domains. A. 3IJE
αVβ3-1TM. B. 4G1M αVβ3-1TM. C. αVβ3-AB. Shown are the C-terminal αV and β3
extensions together with the C-terminal portions of calf-2 and β-tail domains as a Cα-
ribbon, together with sidechains and backbones of selected regions. Hydrogen bonds near
the end of the calf-2 and β-tail domains are shown as red dashed lines. Electron density is
shown as mesh around αV residues 755 and 953-967 and β3 residues 663 and 685-695.
Mesh for 1 σ 2Fo-Fc, -3 σ Fo-Fc, and 3 σ Fo-Fc electron density is shown in blue, red, and
green, respectively. CCP4 format maps were opened and displayed with the isomesh
command in PyMol using carve = 2.4 and 1.9 Å for 2Fo-Fc and Fo-Fc maps, respectively.
Mesh was calculated in A using 3IJE data and in B using 4G1M data. In each of A and B,
mesh was separately calculated (carved) around the positions of atoms in both the 3IJE and
4G1M models, and the combined mesh is displayed. The view is similar to that in Fig. 4A of
(14).
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Table 1
Statistics of X-ray diffraction and structure refinement
Protein αVβ3-AB αVβ3-1TM
Data collection statistics
Space group P3221 P3221
α, β, γ,° 90, 90, 120 90, 90, 120
Unit cell (a = b, c), Å 128.46, 352.49 130.26, 305.98
Resolution range (Å) 50.0-2.85(2.85-2.92) 65-2.9
Completeness (%) 99.9 (100.0) 99.2 (98.5)
Number of unique reflections 79,656 (5,806) 66,702 (6,515)
Redundancy 7.4 (6.6) 2.9 (2.2)






Wavelength (Å) 1.034 1.0332
Refinement statistics 4G1E 3IJE 4G1M
Resolution range (Å) 50.0-2.85 20-2.9 65-2.9
Rwork (%) 24.1 24.4 18.0
Rfree (%) 26.1 28.7 23.4
Model statistics
Bond RMSD (Å) 0.005 0.006 0.005










α V 1-619, 621-838, 841-848, 867-959 1-838, 868-967 1-837, 868-959
β 3 1-33, 35-478, 483-691 1-695 1-692
Number of metals 6 6 7
Number of carbohydrates 48 34 37
Number of cis-Proline 7 0 7
Number of waters 104 0 108
‡
The number in parentheses cannot be correct, but cannot be recalculated by us, and is shown as originally reported.
a
The numbers in parentheses refer to the highest resolution shell.
b
Rmerge = Σh Σi |Ii(h) -<I(h)> | / ΣhΣi Ii(h), where Ii(h) and <I(h)> are the ith and mean measurement of the intensity of reflection h.
c
Rfactor = Σh||Fobs (h)|-|Fcalc (h)|| / Σh|Fobs (h)|, where Fobs (h) and Fcalc (h) are the observed and calculated structure factors, respectively. No
I/σ cutoff was applied.
d
Calculated with the described server (30).
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e
Pearson's correlation coefficient between average intensities of random half-datasets for unique reflection (28).
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Table 2
RMSDs between 3IJE and 4G1M αVβ3-1TM structures.a
Domain Residues 3IJE/4G1M non-H atoms (Å) 3IJE/4G1M Cα atoms (Å)
PSI 1-56+434-435 1.9 1.4
Hybrid 57-108+353-433 1.4 0.5
βI 109-352 1.3 0.7
I-EGF1 436-472 1.9 1.3
I-EGF2 473-522 2.9 1.4
I-EGF3 523-559 1.2 0.6
I-EGF4 560-600 1.5 0.8
Ankle 601-605 0.4 0.2
β-tail 606-690 1.3 0.7
linker 691-692 1.5 2.1
β-propeller 1-438 0.8 0.3
Thigh 439-594 1.3 0.6
Calf-1 595-737 1.8 0.9
Calf-2 738-954 1.5 1.1
Linker 955-959 2.0 1.6
Overall 1.4 0.8
a
RMSD was calculated using rms_cur command of PyMol.
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